Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, April 30, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
Life Sciences Times
-
April 30, 2026
Pharma
Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study
Life Sciences Times
-
April 30, 2026
Pharma
Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment
Life Sciences Times
-
April 30, 2026
Pharma
Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal
Life Sciences Times
-
April 29, 2026
Pharma
FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer
Life Sciences Times
-
April 28, 2026
Pharma
Ono Pharma seeks Japan approval for ripretinib in advanced gastrointestinal tumor
Life Sciences Times
-
March 26, 2026
0
Pharma
TRIANA Biomedicines Secures FDA Fast Track Status for Lung Cancer Therapy TRI-611
Life Sciences Times
-
March 25, 2026
0
Pharma
Amylyx Completes Enrollment in Phase 3 Trial of Avexitide for Post-Bariatric Hypoglycemia
Life Sciences Times
-
March 24, 2026
0
Pharma
Alnylam Expands Efforts to Improve ATTR-CM Diagnosis and Care Through Strategic Partnerships
Life Sciences Times
-
March 24, 2026
0
Pharma
Sarepta Plans FDA Filings to Convert Duchenne Therapies to Traditional Approval
Life Sciences Times
-
March 19, 2026
0
Pharma
Study Suggests Daily Multivitamin May Slow Biological Aging
Life Sciences Times
-
March 9, 2026
0
Pharma
Parabilis Medicines Reports Early Clinical Data Showing Zolucatetide Reduces Polyp Burden in Familial Adenomatous Polyposis
Life Sciences Times
-
March 5, 2026
0
Pharma
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
Life Sciences Times
-
March 3, 2026
0
Pharma
KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings
Life Sciences Times
-
March 2, 2026
0
Pharma
Merck Unveils Late-Breaking Phase 3 Data on Doravirine/Islatravir HIV Regimen at CROI 2026
Life Sciences Times
-
February 26, 2026
0
Pharma
Asahi Kasei Pharma Expands Preclinical Pipeline With Global Licensing Deal for Novel Compounds
Life Sciences Times
-
February 25, 2026
0
Pharma
Ironwood Pharmaceuticals Reports 2025 Results, Meets Guidance and Reaffirms Strong 2026 Outlook
Life Sciences Times
-
February 25, 2026
0
1
2
3
4
...
91
Page 3 of 91
Most Read
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
April 30, 2026
Johnson & Johnson Names Ryan Koors Vice President of Investor Relations
April 30, 2026
Moleculent Raises $20 Million to Expand Functional Profiling Platform
April 30, 2026
Komodo Health Names Paul Thomas Chief Financial Officer
April 30, 2026